Recalls

All Class I Class II Class III

18,166 recalls

II Nexterone (amiodarone HCI), 360 mg/200 mL (1.8 mg/mL) in GALAXY Single-Dose Container, sterile, Nonpyrogenic, iso-osmoti… CGMP Deviations Baxter Healthcare Corporation · Sep 9, 2026 II CARDENE IV (Nicardipine Hydrochloride) in 0.83% Sodium Chloride Injection, 40 mg in 200 mL (0.2 mg/mL) in GALAXY Single-… CGMP Deviations Baxter Healthcare Corporation · Sep 9, 2026 II Pantoprazole Sodium in 0.9% Sodium Chloride Injection, 80 mg/100 mL (0.8 mg/mL) Single-Dose Infusion Bag in 100 mL GALAX… CGMP Deviations Baxter Healthcare Corporation · Sep 9, 2026 II Vasopressin, in 0.9% Sodium Chloride Injection, 20 units per 100 mL (0.2 units/mL), 100mL Single-Dose Container, Rx only… CGMP Deviations Baxter Healthcare Corporation · Sep 9, 2026 II Dexmedetomidine Hydrochloride in 0.9% Sodium Chloride Injection, 400 mcg per 100 mL (4 mcg/mL) in Galaxy 100 mL Single D… CGMP Deviations Baxter Healthcare Corporation · Sep 9, 2026 II Famotidine Injection in Sodium Chloride Injection, 20 mg, 50 mL in GALAXY Single Dose Container, Rx Only, Sterile Nonpyr… CGMP Deviations Baxter Healthcare Corporation · Sep 9, 2026 II Clindamycin Injection USP in 5% Dextrose, 600 mg per 50 mL (12 mg/mL) in GALAXY 50 mL Single Dose Container, Rx only, St… CGMP Deviations Baxter Healthcare Corporation · Sep 9, 2026 II Daptomycin, in 0.9% Sodium Chloride Injection, 500 mg per 50 mL (10 mg/mL), 500 mg total, in 50 mL Single Dose Container… CGMP Deviations Baxter Healthcare Corporation · Sep 9, 2026 II MYXREDLIN, Insulin Human in 0.9% Sodium Chloride Injection, 100 units/100 mL (1 unit/mL), Rx only, Baxter Healthcare Cor… CGMP Deviations Baxter Healthcare Corporation · Sep 9, 2026 II Vancomycin Injection, USP in 5% Dextrose, 1 g per 200mL (5 mg/mL), in GALAXY Single-Dose Container, Rx only, Sterile Non… CGMP Deviations Baxter Healthcare Corporation · Sep 9, 2026 I Lactated Ringer's Injection USP, 1000 mL EXCEL container, Rx only, L7500, B. Presence of Particulate matter. B Braun Medical Inc · Sep 2, 2026 II Ramipril Capsules USP, 10 mg, packaged in a) 100 Capsules (NDC 76282-673-01) and b) 500 Capsules (NDC 76282-673-05) bott… Failed Impurities/Degradation Specifications: OOS result obtained for a process impurity, dicyclohexylurea (DCU). Hikma Pharmaceuticals USA INC. · Sep 2, 2026 I Tyenne (tocilizumab-aazg) Injection, 400 mg/20 mL (20 mg/mL), 20 mL vial, Rx Only, Manufactured by Fresenius Kabi USA, L… Presence of particulate matter:An internal investigation at the firm found the product to contain glass particles. Fresenius Kabi USA, LLC · Sep 2, 2026 II Paxil CR, Paroxetine, Extended-Release Tablets, 37.5mg, 30 count bottle, Rx only, Manufactured by: Apotex Inc., Toronto,… Failed Dissolution Specifications; product failed to meet 24-month stability testing acceptance criteria Apotex Corp. · Sep 2, 2026 II Acthar Gel (repository corticotropin injection), 5 mL multiple-dose vial, Rx Only, Mfd. Presence of particulate matter: glass and stopper piece Mallinckrodt Hospital Products Inc. · Sep 2, 2026 II Zicam, Cold Remedy, Medicated Nasal Swabs, With Cooling Menthol & Eucalyptus, 20 Single-Use Swabs per carton, Zinc-Free… CGMP Deviations; FDA inspection of the contract manufacturer noted out of limit results for microbiological testing Church & Dwight Co., Inc. · Sep 2, 2026 II Clobetasol Propionate Cream USP, 0.05%, 60 g tube, Rx Only, Manufactured for: Lupin Pharmaceuticals, Inc., Naples, FL 34… Failed content uniformity specifications. Lupin Pharmaceuticals Inc. · Sep 2, 2026 II Levothyroxine Sodium Tablets, USP, 300 mcg (0.3 mg), 90-count bottles, Rx Only, Manufactured for: Accord Healthcare, Inc… Subpotent Drug Accord Healthcare, Inc. · Sep 2, 2026 II Levothyroxine Sodium Tablets, USP, 200 mcg (0.2 mg), packaged in a) 90-count bottles (NDC 16729-457-15) and b) 1000-coun… Subpotent Drug Accord Healthcare, Inc. · Sep 2, 2026 II Levothyroxine Sodium Tablets, USP, 175 mcg (0.175 mg), packaged in a) 90-count bottles (NDC 16729-456-15), and b) 1000-c… Subpotent Drug Accord Healthcare, Inc. · Sep 2, 2026